CGN Nuclear Technology Development（000881）株式概要CGN原子力技術開発株式会社 詳細000881 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性4/6配当金0/6リスク分析過去5年間で収益は年間53.3%減少しました。 すべてのリスクチェックを見る000881 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueCN¥Current PriceCN¥7.8530.6% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-777m9b2016201920222025202620282031Revenue CN¥3.8bEarnings CN¥353.4mAdvancedSet Fair ValueView all narrativesCGN Nuclear Technology Development Co., Ltd. 競合他社Liaoning OxiranchemIncSymbol: SZSE:300082Market cap: CN¥7.5bSino-High (China)Symbol: SZSE:301076Market cap: CN¥7.3bJiangsu Canlon Building MaterialsSymbol: SZSE:300715Market cap: CN¥8.1bSobute New MaterialsSymbol: SHSE:603916Market cap: CN¥6.7b価格と性能株価の高値、安値、推移の概要CGN Nuclear Technology Development過去の株価現在の株価CN¥7.8552週高値CN¥9.6952週安値CN¥7.14ベータ0.461ヶ月の変化3.29%3ヶ月変化-7.65%1年変化-2.36%3年間の変化-1.01%5年間の変化-28.38%IPOからの変化72.98%最新ニュースReported Earnings • Apr 28Full year 2025 earnings released: CN¥0.30 loss per share (vs CN¥0.38 loss in FY 2024)Full year 2025 results: CN¥0.30 loss per share (improved from CN¥0.38 loss in FY 2024). Revenue: CN¥5.55b (down 10.0% from FY 2024). Net loss: CN¥287.1m (loss narrowed 21% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has remained flat, which means it is well ahead of earnings.お知らせ • Apr 28CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 18, 2026CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 18, 2026, at 15:00 China Standard Time. Location: The Company's Meeting Room, Shenzhen, Guangdong Chinaお知らせ • Mar 31CGN Nuclear Technology Development Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026CGN Nuclear Technology Development Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026お知らせ • Dec 31CGN Nuclear Technology Development Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026CGN Nuclear Technology Development Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026Reported Earnings • Oct 31Third quarter 2025 earnings released: CN¥0.002 loss per share (vs CN¥0.05 loss in 3Q 2024)Third quarter 2025 results: CN¥0.002 loss per share (improved from CN¥0.05 loss in 3Q 2024). Revenue: CN¥1.47b (down 12% from 3Q 2024). Net loss: CN¥2.02m (loss narrowed 96% from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.お知らせ • Sep 30CGN Nuclear Technology Development Co., Ltd. to Report Q3, 2025 Results on Oct 31, 2025CGN Nuclear Technology Development Co., Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025最新情報をもっと見るRecent updatesReported Earnings • Apr 28Full year 2025 earnings released: CN¥0.30 loss per share (vs CN¥0.38 loss in FY 2024)Full year 2025 results: CN¥0.30 loss per share (improved from CN¥0.38 loss in FY 2024). Revenue: CN¥5.55b (down 10.0% from FY 2024). Net loss: CN¥287.1m (loss narrowed 21% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has remained flat, which means it is well ahead of earnings.お知らせ • Apr 28CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 18, 2026CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 18, 2026, at 15:00 China Standard Time. Location: The Company's Meeting Room, Shenzhen, Guangdong Chinaお知らせ • Mar 31CGN Nuclear Technology Development Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026CGN Nuclear Technology Development Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026お知らせ • Dec 31CGN Nuclear Technology Development Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026CGN Nuclear Technology Development Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026Reported Earnings • Oct 31Third quarter 2025 earnings released: CN¥0.002 loss per share (vs CN¥0.05 loss in 3Q 2024)Third quarter 2025 results: CN¥0.002 loss per share (improved from CN¥0.05 loss in 3Q 2024). Revenue: CN¥1.47b (down 12% from 3Q 2024). Net loss: CN¥2.02m (loss narrowed 96% from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.お知らせ • Sep 30CGN Nuclear Technology Development Co., Ltd. to Report Q3, 2025 Results on Oct 31, 2025CGN Nuclear Technology Development Co., Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025お知らせ • Jul 02CGN Nuclear Technology Development Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025CGN Nuclear Technology Development Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025New Risk • Jun 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 64% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).お知らせ • Jun 09CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, Jun 30, 2025CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, Jun 30, 2025, at 14:30 China Standard Time. Location: 19F, North Tower, No. 2002, Shennan Avenue, Futian District, Shenzhen, Guangdong ChinaReported Earnings • Apr 29Full year 2024 earnings released: CN¥0.38 loss per share (vs CN¥0.78 loss in FY 2023)Full year 2024 results: CN¥0.38 loss per share (improved from CN¥0.78 loss in FY 2023). Revenue: CN¥6.17b (down 2.9% from FY 2023). Net loss: CN¥362.2m (loss narrowed 51% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance.お知らせ • Apr 01CGN Nuclear Technology Development Co., Ltd. Approves the Election of Yu Haifeng as Non-Independent DirectorCGN Nuclear Technology Development Co., Ltd. held its 2nd Extraordinary General Meeting of 2025 on 28 March 2025, during which the following proposal(s) was/were approved: Election of Yu Haifeng as a non-independent director.お知らせ • Mar 31CGN Nuclear Technology Development Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025CGN Nuclear Technology Development Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025お知らせ • Feb 18CGN Nuclear Technology Development Co., Ltd. Approves Board ElectionsCGN Nuclear Technology Development Co., Ltd. at its Extraordinary General Meeting held on 14 February 2025, approved the election of Wang Man and He Fei as non-independent director.お知らせ • Dec 31CGN Nuclear Technology Development Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025CGN Nuclear Technology Development Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025Reported Earnings • Oct 31Third quarter 2024 earnings released: CN¥0.05 loss per share (vs CN¥0.001 profit in 3Q 2023)Third quarter 2024 results: CN¥0.05 loss per share (down from CN¥0.001 profit in 3Q 2023). Revenue: CN¥1.67b (flat on 3Q 2023). Net loss: CN¥47.8m (down CN¥48.7m from profit in 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 108 percentage points per year, which is a significant difference in performance.分析記事 • Oct 28CGN Nuclear Technology Development Co., Ltd.'s (SZSE:000881) Revenues Are Not Doing Enough For Some InvestorsYou may think that with a price-to-sales (or "P/S") ratio of 1.1x CGN Nuclear Technology Development Co., Ltd...お知らせ • Sep 30CGN Nuclear Technology Development Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024CGN Nuclear Technology Development Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024お知らせ • Aug 30CGN Nuclear Technology Development Co., Ltd. Approves Election of Mou Wenjun as A Non-Independent DirectorCGN Nuclear Technology Development Co., Ltd. held its Extraordinary General Meeting of 2024 on 28 August 2024 approved Election of Mou Wenjun as a non-independent director.お知らせ • Jun 29CGN Nuclear Technology Development Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024CGN Nuclear Technology Development Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024分析記事 • Jun 07We Think CGN Nuclear Technology Development (SZSE:000881) Has A Fair Chunk Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...お知らせ • Apr 29CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 17, 2024CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 17, 2024, at 14:30 China Standard Time. Location: 19F, North Tower, No. 2002, Shennan Avenue, Futian District, Shenzhen, Guangdong China分析記事 • Apr 26The Market Doesn't Like What It Sees From CGN Nuclear Technology Development Co., Ltd.'s (SZSE:000881) Revenues YetYou may think that with a price-to-sales (or "P/S") ratio of 1.2x CGN Nuclear Technology Development Co., Ltd...お知らせ • Mar 30CGN Nuclear Technology Development Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024CGN Nuclear Technology Development Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024お知らせ • Jan 16CGN Nuclear Technology Development Co., Ltd. Approves Board ElectionsCGN Nuclear Technology Development Co., Ltd. announced that at its EGM held on 12 January 2024, the shareholders approved election of Mu Changkun and Wu Yuanming as non-independent directors of the company.お知らせ • Dec 30CGN Nuclear Technology Development Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024CGN Nuclear Technology Development Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024New Risk • Dec 21New major risk - Revenue and earnings growthEarnings have declined by 23% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Cash payout ratio: 242% Earnings have declined by 23% per year over the past 5 years.Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.001 (vs CN¥0.092 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.001 (down from CN¥0.092 in 3Q 2022). Revenue: CN¥1.68b (down 23% from 3Q 2022). Net income: CN¥939.9k (down 99% from 3Q 2022). Profit margin: 0.1% (down from 4.0% in 3Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.Reported Earnings • Aug 26Second quarter 2023 earnings released: CN¥0.084 loss per share (vs CN¥0.091 profit in 2Q 2022)Second quarter 2023 results: CN¥0.084 loss per share (down from CN¥0.091 profit in 2Q 2022). Revenue: CN¥1.64b (down 30% from 2Q 2022). Net loss: CN¥78.9m (down 192% from profit in 2Q 2022). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.お知らせ • Jun 02CGN Nuclear Technology Development Co., Ltd. Announces Cash Dividend of A Shares for the Year 2022, Payment Date Is 07 June 2023CGN Nuclear Technology Development Co., Ltd. announced cash dividend/10 shares (tax included) of CNY 0.4000000 of A shares for the year 2022. Record date is 06 June 2023. Ex-date is 07 June 2023. Payment date 07 June 2023.Reported Earnings • Apr 28First quarter 2023 earnings released: CN¥0.027 loss per share (vs CN¥0.04 profit in 1Q 2022)First quarter 2023 results: CN¥0.027 loss per share (down from CN¥0.04 profit in 1Q 2022). Revenue: CN¥1.23b (down 38% from 1Q 2022). Net loss: CN¥25.7m (down 168% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.Board Change • Feb 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Non-Employee Supervisor Jun Wang was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jan 21CGN Nuclear Technology Development Co., Ltd. Approves Management ElectionsCGN Nuclear Technology Development Co., Ltd. at its Extraordinary General Meeting held on 19 January 2023 approved election of Sheng Guofu and Wen Zhitao as non-independent director, Huang Xiaoyan and Kang Xiaoyue as independent director and Yang Jun and Wang Jun as non-employee supervisor.Board Change • Nov 16Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Independent Director Chengqing Liu is the most experienced director on the board, commencing their role in 2020. Independent Director Guangguo Sun was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Reported Earnings • Oct 31Third quarter 2022 earnings released: EPS: CN¥0.092 (vs CN¥0.079 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.092 (up from CN¥0.079 in 3Q 2021). Revenue: CN¥2.17b (up 1.2% from 3Q 2021). Net income: CN¥87.5m (up 17% from 3Q 2021). Profit margin: 4.0% (up from 3.5% in 3Q 2021). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 28Second quarter 2022 earnings released: EPS: CN¥0.091 (vs CN¥0.11 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.091 (down from CN¥0.11 in 2Q 2021). Revenue: CN¥2.35b (up 24% from 2Q 2021). Net income: CN¥85.7m (down 19% from 2Q 2021). Profit margin: 3.6% (down from 5.6% in 2Q 2021). Over the next year, revenue is forecast to grow 3.1%, compared to a 39% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year.お知らせ • Jun 23CGN Nuclear Technology Development Co., Ltd. Announces Final Cash Dividend on A Shares for 2021, Payable on 29 June 2022CGN Nuclear Technology Development Co., Ltd. announced final cash dividend of CNY 0.35000000 per 10 shares on A shares for 2021. Record date is 28 June 2022, Ex-date is 29 June 2022 and Payment date is 29 June 2022.お知らせ • May 24Cgn Nuclear Technology Development Co., Ltd. Approves Cash Dividend for the Year 2021CGN Nuclear Technology Development Co., Ltd. announced at annual general meeting held on May 20, 2022, the shareholders approved the cash dividend of CNY 0.35000000 per ten shares (tax included) for the year 2021.お知らせ • May 08CGN Nuclear Technology Development Co., Ltd. Proposes Final Cash Dividend for the Year 2021CGN Nuclear Technology Development Co., Ltd. proposed final Cash dividend/10 shares (tax included): CNY 0.35000000 for the year 2021.お知らせ • May 07CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 20, 2022CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 20, 2022, at 14:30 China Standard Time. Agenda: To consider 2021 work report of the board of directors; to consider 2021 work report of the supervisory committee; to consider Settlement of some projects financed with raised funds and permanently supplementing the working capital with the surplus raised funds; to consider 2021 annual accounts; to consider 2022 investment and budget report; to consider 2021 profit distribution plan; to consider 2022 bank credit and financing plan; to consider Confirmation of 2021 continuing connected transactions amount and 2022 estimated amount of continuing connected transactions; and to consider 2021 annual report and its summary.Reported Earnings • May 02First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2022 results: EPS: CN¥0.04 (up from CN¥0.025 in 1Q 2021). Revenue: CN¥1.96b (up 37% from 1Q 2021). Net income: CN¥38.1m (up 63% from 1Q 2021). Profit margin: 1.9% (up from 1.6% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 6.4%. Earnings per share (EPS) missed analyst estimates by 43%. Over the next year, revenue is forecast to grow 1.1%, compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has remained flat.Board Change • Apr 27Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Independent Director Chengqing Liu is the most experienced director on the board, commencing their role in 2020. Independent Director Guangguo Sun was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥10.24, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 14% over the past three years.Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.079 (vs CN¥0.058 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥2.14b (up 21% from 3Q 2020). Net income: CN¥74.7m (up 37% from 3Q 2020). Profit margin: 3.5% (up from 3.1% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.Reported Earnings • Aug 30Second quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.28 in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.90b (down 6.3% from 2Q 2020). Net income: CN¥106.0m (down 59% from 2Q 2020). Profit margin: 5.6% (down from 13% in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.お知らせ • May 02CGN Nuclear Technology Development Co., Ltd. Proposes Final Cash Dividend for the Year 2020CGN Nuclear Technology Development Co., Ltd. proposed final Cash dividend/10 shares (tax included): CNY 0.33000000 for the year 2020.Reported Earnings • May 02First quarter 2021 earnings released: EPS CN¥0.025 (vs CN¥0.066 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.43b (up 53% from 1Q 2020). Net income: CN¥23.4m (up CN¥85.6m from 1Q 2020). Profit margin: 1.6% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.Reported Earnings • Apr 17Full year 2020 earnings released: EPS CN¥0.29 (vs CN¥0.10 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: CN¥6.65b (down 5.3% from FY 2019). Net income: CN¥271.1m (up 164% from FY 2019). Profit margin: 4.1% (up from 1.5% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥12.83, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 12% over the past three years.Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥12.60, the stock trades at a trailing P/E ratio of 43.3x, up from the previous P/E ratio of 37.1x. Average P/E is 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 3.3%.Is New 90 Day High Low • Mar 15New 90-day high: CN¥12.08The company is up 38% from a price of CN¥8.73 on 15 December 2020. Outperformed the Chinese market which is flat over the last 90 days. Exceeded the Chemicals industry, which is up 11% over the same period.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥9.32, the stock is trading at a trailing P/E ratio of 32.1x, down from the previous P/E ratio of 38x. This compares to an average P/E of 34x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 14%.Is New 90 Day High Low • Jan 15New 90-day high: CN¥11.22The company is up 14% from its price of CN¥9.80 on 16 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥49.33 per share.Is New 90 Day High Low • Dec 29New 90-day high: CN¥10.73The company is up 13% from its price of CN¥9.50 on 30 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 22% share price gain to CN¥10.73, the stock is trading at a trailing P/E ratio of 36.9x, up from the previous P/E ratio of 30.2x. This compares to an average P/E of 35x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 17%.Reported Earnings • Oct 30Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥280.7m, up 37% from the prior year. Total revenue was CN¥7.10b over the last 12 months, up 6.7% from the prior year.Is New 90 Day High Low • Oct 30New 90-day low: CN¥8.81The company is down 5.0% from its price of CN¥9.23 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.お知らせ • Aug 14CGN Nuclear Technology Development Co., Ltd. to Report First Half, 2020 Results on Aug 31, 2020CGN Nuclear Technology Development Co., Ltd. announced that they will report first half, 2020 results on Aug 31, 2020株主還元000881CN ChemicalsCN 市場7D-0.5%-1.3%-0.05%1Y-2.4%61.9%34.9%株主還元を見る業界別リターン: 000881過去 1 年間で61.9 % の収益を上げたCN Chemicals業界を下回りました。リターン対市場: 000881は、過去 1 年間で34.9 % のリターンを上げたCN市場を下回りました。価格変動Is 000881's price volatile compared to industry and market?000881 volatility000881 Average Weekly Movement4.6%Chemicals Industry Average Movement6.8%Market Average Movement6.4%10% most volatile stocks in CN Market10.1%10% least volatile stocks in CN Market4.2%安定した株価: 000881 、 CN市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 000881の 週次ボラティリティ ( 5% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト19934,338n/awww.cgnnt.com.cnCGN核科技発展有限公司は、中国でケーブル材料と産業用電子加速器を製造・販売している。地上ナノ加速器、電子カーテン加速器、DG共振トランス加速器、工業用探傷加速器などを提供。また、特殊廃棄物の電子ビーム処理、抗生物質残留物処理技術、医薬廃水処理技術、医療下水・固形廃棄物処理、公園下水処理、印刷・染色廃水処理技術、石炭化学コークス廃水処理技術、化学廃水処理技術、国内下水処理技術、有害廃棄物濃縮処理サービスの提供にも携わっている。さらに、新エネルギー、放射線照射、エラストマー、合成素材、改質ポリカーボネートとポリエステル、改質ポリプロピレン、連続繊維強化熱可塑性プラスチック複合材料、メルトブローと耐放射線ポリプロピレン、陽子線治療腫瘍システム機器、原材料と部品、放射性医療アイソトープ、病院と核医薬品を提供している。さらに、プラスチックの製造・販売、不動産開発、請負、照射加工、外航海運、海上貨物輸送、船舶投資・用船、漁業、プロジェクト建設事業にも取り組んでいる。同社は以前、中国大連国際合作（集団）控股有限公司として知られ、2017年2月にCGN核科技発展有限公司に社名を変更した。CGN核科技発展有限公司は1993年に設立され、中国の深センに拠点を置いている。もっと見るCGN Nuclear Technology Development Co., Ltd. 基礎のまとめCGN Nuclear Technology Development の収益と売上を時価総額と比較するとどうか。000881 基礎統計学時価総額CN¥7.42b収益（TTM）-CN¥280.94m売上高(TTM)CN¥5.57b1.3xP/Sレシオ-26.4xPER（株価収益率000881 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計000881 損益計算書（TTM）収益CN¥5.57b売上原価CN¥4.79b売上総利益CN¥777.78mその他の費用CN¥1.06b収益-CN¥280.94m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）-0.30グロス・マージン13.96%純利益率-5.04%有利子負債／自己資本比率48.9%000881 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/25 21:43終値2026/05/25 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋CGN Nuclear Technology Development Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Yanli QiBohai Securities Co., Ltd.
Reported Earnings • Apr 28Full year 2025 earnings released: CN¥0.30 loss per share (vs CN¥0.38 loss in FY 2024)Full year 2025 results: CN¥0.30 loss per share (improved from CN¥0.38 loss in FY 2024). Revenue: CN¥5.55b (down 10.0% from FY 2024). Net loss: CN¥287.1m (loss narrowed 21% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
お知らせ • Apr 28CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 18, 2026CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 18, 2026, at 15:00 China Standard Time. Location: The Company's Meeting Room, Shenzhen, Guangdong China
お知らせ • Mar 31CGN Nuclear Technology Development Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026CGN Nuclear Technology Development Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026
お知らせ • Dec 31CGN Nuclear Technology Development Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026CGN Nuclear Technology Development Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026
Reported Earnings • Oct 31Third quarter 2025 earnings released: CN¥0.002 loss per share (vs CN¥0.05 loss in 3Q 2024)Third quarter 2025 results: CN¥0.002 loss per share (improved from CN¥0.05 loss in 3Q 2024). Revenue: CN¥1.47b (down 12% from 3Q 2024). Net loss: CN¥2.02m (loss narrowed 96% from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
お知らせ • Sep 30CGN Nuclear Technology Development Co., Ltd. to Report Q3, 2025 Results on Oct 31, 2025CGN Nuclear Technology Development Co., Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025
Reported Earnings • Apr 28Full year 2025 earnings released: CN¥0.30 loss per share (vs CN¥0.38 loss in FY 2024)Full year 2025 results: CN¥0.30 loss per share (improved from CN¥0.38 loss in FY 2024). Revenue: CN¥5.55b (down 10.0% from FY 2024). Net loss: CN¥287.1m (loss narrowed 21% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
お知らせ • Apr 28CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 18, 2026CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 18, 2026, at 15:00 China Standard Time. Location: The Company's Meeting Room, Shenzhen, Guangdong China
お知らせ • Mar 31CGN Nuclear Technology Development Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026CGN Nuclear Technology Development Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026
お知らせ • Dec 31CGN Nuclear Technology Development Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026CGN Nuclear Technology Development Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026
Reported Earnings • Oct 31Third quarter 2025 earnings released: CN¥0.002 loss per share (vs CN¥0.05 loss in 3Q 2024)Third quarter 2025 results: CN¥0.002 loss per share (improved from CN¥0.05 loss in 3Q 2024). Revenue: CN¥1.47b (down 12% from 3Q 2024). Net loss: CN¥2.02m (loss narrowed 96% from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
お知らせ • Sep 30CGN Nuclear Technology Development Co., Ltd. to Report Q3, 2025 Results on Oct 31, 2025CGN Nuclear Technology Development Co., Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025
お知らせ • Jul 02CGN Nuclear Technology Development Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025CGN Nuclear Technology Development Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025
New Risk • Jun 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 64% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).
お知らせ • Jun 09CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, Jun 30, 2025CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, Jun 30, 2025, at 14:30 China Standard Time. Location: 19F, North Tower, No. 2002, Shennan Avenue, Futian District, Shenzhen, Guangdong China
Reported Earnings • Apr 29Full year 2024 earnings released: CN¥0.38 loss per share (vs CN¥0.78 loss in FY 2023)Full year 2024 results: CN¥0.38 loss per share (improved from CN¥0.78 loss in FY 2023). Revenue: CN¥6.17b (down 2.9% from FY 2023). Net loss: CN¥362.2m (loss narrowed 51% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 01CGN Nuclear Technology Development Co., Ltd. Approves the Election of Yu Haifeng as Non-Independent DirectorCGN Nuclear Technology Development Co., Ltd. held its 2nd Extraordinary General Meeting of 2025 on 28 March 2025, during which the following proposal(s) was/were approved: Election of Yu Haifeng as a non-independent director.
お知らせ • Mar 31CGN Nuclear Technology Development Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025CGN Nuclear Technology Development Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025
お知らせ • Feb 18CGN Nuclear Technology Development Co., Ltd. Approves Board ElectionsCGN Nuclear Technology Development Co., Ltd. at its Extraordinary General Meeting held on 14 February 2025, approved the election of Wang Man and He Fei as non-independent director.
お知らせ • Dec 31CGN Nuclear Technology Development Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025CGN Nuclear Technology Development Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025
Reported Earnings • Oct 31Third quarter 2024 earnings released: CN¥0.05 loss per share (vs CN¥0.001 profit in 3Q 2023)Third quarter 2024 results: CN¥0.05 loss per share (down from CN¥0.001 profit in 3Q 2023). Revenue: CN¥1.67b (flat on 3Q 2023). Net loss: CN¥47.8m (down CN¥48.7m from profit in 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 108 percentage points per year, which is a significant difference in performance.
分析記事 • Oct 28CGN Nuclear Technology Development Co., Ltd.'s (SZSE:000881) Revenues Are Not Doing Enough For Some InvestorsYou may think that with a price-to-sales (or "P/S") ratio of 1.1x CGN Nuclear Technology Development Co., Ltd...
お知らせ • Sep 30CGN Nuclear Technology Development Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024CGN Nuclear Technology Development Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024
お知らせ • Aug 30CGN Nuclear Technology Development Co., Ltd. Approves Election of Mou Wenjun as A Non-Independent DirectorCGN Nuclear Technology Development Co., Ltd. held its Extraordinary General Meeting of 2024 on 28 August 2024 approved Election of Mou Wenjun as a non-independent director.
お知らせ • Jun 29CGN Nuclear Technology Development Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024CGN Nuclear Technology Development Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024
分析記事 • Jun 07We Think CGN Nuclear Technology Development (SZSE:000881) Has A Fair Chunk Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
お知らせ • Apr 29CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 17, 2024CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 17, 2024, at 14:30 China Standard Time. Location: 19F, North Tower, No. 2002, Shennan Avenue, Futian District, Shenzhen, Guangdong China
分析記事 • Apr 26The Market Doesn't Like What It Sees From CGN Nuclear Technology Development Co., Ltd.'s (SZSE:000881) Revenues YetYou may think that with a price-to-sales (or "P/S") ratio of 1.2x CGN Nuclear Technology Development Co., Ltd...
お知らせ • Mar 30CGN Nuclear Technology Development Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024CGN Nuclear Technology Development Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024
お知らせ • Jan 16CGN Nuclear Technology Development Co., Ltd. Approves Board ElectionsCGN Nuclear Technology Development Co., Ltd. announced that at its EGM held on 12 January 2024, the shareholders approved election of Mu Changkun and Wu Yuanming as non-independent directors of the company.
お知らせ • Dec 30CGN Nuclear Technology Development Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024CGN Nuclear Technology Development Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024
New Risk • Dec 21New major risk - Revenue and earnings growthEarnings have declined by 23% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Cash payout ratio: 242% Earnings have declined by 23% per year over the past 5 years.
Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.001 (vs CN¥0.092 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.001 (down from CN¥0.092 in 3Q 2022). Revenue: CN¥1.68b (down 23% from 3Q 2022). Net income: CN¥939.9k (down 99% from 3Q 2022). Profit margin: 0.1% (down from 4.0% in 3Q 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
Reported Earnings • Aug 26Second quarter 2023 earnings released: CN¥0.084 loss per share (vs CN¥0.091 profit in 2Q 2022)Second quarter 2023 results: CN¥0.084 loss per share (down from CN¥0.091 profit in 2Q 2022). Revenue: CN¥1.64b (down 30% from 2Q 2022). Net loss: CN¥78.9m (down 192% from profit in 2Q 2022). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
お知らせ • Jun 02CGN Nuclear Technology Development Co., Ltd. Announces Cash Dividend of A Shares for the Year 2022, Payment Date Is 07 June 2023CGN Nuclear Technology Development Co., Ltd. announced cash dividend/10 shares (tax included) of CNY 0.4000000 of A shares for the year 2022. Record date is 06 June 2023. Ex-date is 07 June 2023. Payment date 07 June 2023.
Reported Earnings • Apr 28First quarter 2023 earnings released: CN¥0.027 loss per share (vs CN¥0.04 profit in 1Q 2022)First quarter 2023 results: CN¥0.027 loss per share (down from CN¥0.04 profit in 1Q 2022). Revenue: CN¥1.23b (down 38% from 1Q 2022). Net loss: CN¥25.7m (down 168% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
Board Change • Feb 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Non-Employee Supervisor Jun Wang was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jan 21CGN Nuclear Technology Development Co., Ltd. Approves Management ElectionsCGN Nuclear Technology Development Co., Ltd. at its Extraordinary General Meeting held on 19 January 2023 approved election of Sheng Guofu and Wen Zhitao as non-independent director, Huang Xiaoyan and Kang Xiaoyue as independent director and Yang Jun and Wang Jun as non-employee supervisor.
Board Change • Nov 16Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Independent Director Chengqing Liu is the most experienced director on the board, commencing their role in 2020. Independent Director Guangguo Sun was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Reported Earnings • Oct 31Third quarter 2022 earnings released: EPS: CN¥0.092 (vs CN¥0.079 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.092 (up from CN¥0.079 in 3Q 2021). Revenue: CN¥2.17b (up 1.2% from 3Q 2021). Net income: CN¥87.5m (up 17% from 3Q 2021). Profit margin: 4.0% (up from 3.5% in 3Q 2021). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 28Second quarter 2022 earnings released: EPS: CN¥0.091 (vs CN¥0.11 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.091 (down from CN¥0.11 in 2Q 2021). Revenue: CN¥2.35b (up 24% from 2Q 2021). Net income: CN¥85.7m (down 19% from 2Q 2021). Profit margin: 3.6% (down from 5.6% in 2Q 2021). Over the next year, revenue is forecast to grow 3.1%, compared to a 39% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year.
お知らせ • Jun 23CGN Nuclear Technology Development Co., Ltd. Announces Final Cash Dividend on A Shares for 2021, Payable on 29 June 2022CGN Nuclear Technology Development Co., Ltd. announced final cash dividend of CNY 0.35000000 per 10 shares on A shares for 2021. Record date is 28 June 2022, Ex-date is 29 June 2022 and Payment date is 29 June 2022.
お知らせ • May 24Cgn Nuclear Technology Development Co., Ltd. Approves Cash Dividend for the Year 2021CGN Nuclear Technology Development Co., Ltd. announced at annual general meeting held on May 20, 2022, the shareholders approved the cash dividend of CNY 0.35000000 per ten shares (tax included) for the year 2021.
お知らせ • May 08CGN Nuclear Technology Development Co., Ltd. Proposes Final Cash Dividend for the Year 2021CGN Nuclear Technology Development Co., Ltd. proposed final Cash dividend/10 shares (tax included): CNY 0.35000000 for the year 2021.
お知らせ • May 07CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 20, 2022CGN Nuclear Technology Development Co., Ltd., Annual General Meeting, May 20, 2022, at 14:30 China Standard Time. Agenda: To consider 2021 work report of the board of directors; to consider 2021 work report of the supervisory committee; to consider Settlement of some projects financed with raised funds and permanently supplementing the working capital with the surplus raised funds; to consider 2021 annual accounts; to consider 2022 investment and budget report; to consider 2021 profit distribution plan; to consider 2022 bank credit and financing plan; to consider Confirmation of 2021 continuing connected transactions amount and 2022 estimated amount of continuing connected transactions; and to consider 2021 annual report and its summary.
Reported Earnings • May 02First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2022 results: EPS: CN¥0.04 (up from CN¥0.025 in 1Q 2021). Revenue: CN¥1.96b (up 37% from 1Q 2021). Net income: CN¥38.1m (up 63% from 1Q 2021). Profit margin: 1.9% (up from 1.6% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 6.4%. Earnings per share (EPS) missed analyst estimates by 43%. Over the next year, revenue is forecast to grow 1.1%, compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has remained flat.
Board Change • Apr 27Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. 4 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Independent Director Chengqing Liu is the most experienced director on the board, commencing their role in 2020. Independent Director Guangguo Sun was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥10.24, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 14% over the past three years.
Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.079 (vs CN¥0.058 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥2.14b (up 21% from 3Q 2020). Net income: CN¥74.7m (up 37% from 3Q 2020). Profit margin: 3.5% (up from 3.1% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 30Second quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.28 in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.90b (down 6.3% from 2Q 2020). Net income: CN¥106.0m (down 59% from 2Q 2020). Profit margin: 5.6% (down from 13% in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
お知らせ • May 02CGN Nuclear Technology Development Co., Ltd. Proposes Final Cash Dividend for the Year 2020CGN Nuclear Technology Development Co., Ltd. proposed final Cash dividend/10 shares (tax included): CNY 0.33000000 for the year 2020.
Reported Earnings • May 02First quarter 2021 earnings released: EPS CN¥0.025 (vs CN¥0.066 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.43b (up 53% from 1Q 2020). Net income: CN¥23.4m (up CN¥85.6m from 1Q 2020). Profit margin: 1.6% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
Reported Earnings • Apr 17Full year 2020 earnings released: EPS CN¥0.29 (vs CN¥0.10 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: CN¥6.65b (down 5.3% from FY 2019). Net income: CN¥271.1m (up 164% from FY 2019). Profit margin: 4.1% (up from 1.5% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥12.83, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 12% over the past three years.
Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥12.60, the stock trades at a trailing P/E ratio of 43.3x, up from the previous P/E ratio of 37.1x. Average P/E is 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 3.3%.
Is New 90 Day High Low • Mar 15New 90-day high: CN¥12.08The company is up 38% from a price of CN¥8.73 on 15 December 2020. Outperformed the Chinese market which is flat over the last 90 days. Exceeded the Chemicals industry, which is up 11% over the same period.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥9.32, the stock is trading at a trailing P/E ratio of 32.1x, down from the previous P/E ratio of 38x. This compares to an average P/E of 34x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 14%.
Is New 90 Day High Low • Jan 15New 90-day high: CN¥11.22The company is up 14% from its price of CN¥9.80 on 16 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥49.33 per share.
Is New 90 Day High Low • Dec 29New 90-day high: CN¥10.73The company is up 13% from its price of CN¥9.50 on 30 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.
Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 22% share price gain to CN¥10.73, the stock is trading at a trailing P/E ratio of 36.9x, up from the previous P/E ratio of 30.2x. This compares to an average P/E of 35x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 17%.
Reported Earnings • Oct 30Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥280.7m, up 37% from the prior year. Total revenue was CN¥7.10b over the last 12 months, up 6.7% from the prior year.
Is New 90 Day High Low • Oct 30New 90-day low: CN¥8.81The company is down 5.0% from its price of CN¥9.23 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.
お知らせ • Aug 14CGN Nuclear Technology Development Co., Ltd. to Report First Half, 2020 Results on Aug 31, 2020CGN Nuclear Technology Development Co., Ltd. announced that they will report first half, 2020 results on Aug 31, 2020
